The Neutrophil-To-Lymphocyte Ratio (Nlr) As A Predictive Marker Of Response To Abiraterone Acetate: A Retrospective Analysis Of The Cou302 Study

The neutrophil-to-lymphocyte ratio is a common prognostic marker in cancer. This retrospective analysis of a landmark trial of abiraterone versus placebo in men with metastatic, minimally symptomatic castration-resistant prostate cancer demonstrates how it may predict response to abiraterone treatment.